Open AccessSuccessful Management of a Suspected Case of Meperidine-Induced Anaphylaxis in Cesarean Delivery
Author(s) -
Gelareh Biazar,
Farnoush Farzi,
Yasmin Chaibakhsh,
Mohammad Reza Habibi,
Mahsa Sani,
Ladan Mirmansouri
Publication year - 2020
Publication title -
anesthesiology and pain medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.438
H-Index - 26
eISSN - 2228-7531
pISSN - 2228-7523
DOI - 10.5812/aapm.104796
Subject(s) - medicine , shivering , anaphylaxis , anesthesia , intervention (counseling) , cesarean delivery , gold standard (test) , pregnancy , allergy , immunology , psychiatry , biology , genetics
Meperidine is known as the gold standard drug for shivering after spinal anesthesia (SA). This drug has been used widely and safely during the Cesarean Section (CS). Case Presentation: This case report presents an anaphylaxis reaction to a single intravenous dose of 25 mg meperidine, aiming to control shivering during CS under SA a few minutes after surgical incision. Conclusions: The condition was well managed with timely intervention. This rare fetal reaction to meperidine is worthy of reporting to make the medical team aware of the potential risks of anaphylaxis due to many routine safe drugs.